Recorded October 26, 2022 | On-Demand Webinar
Learn the definition of human cellular and tissue-based products (HCT/P) and how to determine whether an HCT/P is regulated solely under regulations issued under Section 361 of the PHS Act. Learn about types of emerging technologies such as cell and gene therapies.
This session was recorded as part of FDLI’s virtual course, "Introduction to Biological Products, Including Vaccines, Biosimilars, Cell and Gene Therapies, and Other Advanced Therapies" in October 2022.